Literature DB >> 23012353

Human histone H3K79 methyltransferase DOT1L protein [corrected] binds actively transcribing RNA polymerase II to regulate gene expression.

Seung-Kyoon Kim1, Inkyung Jung, Hosuk Lee, Keunsoo Kang, Mirang Kim, Kwiwan Jeong, Chang Seob Kwon, Yong-Mahn Han, Yong Sung Kim, Dongsup Kim, Daeyoup Lee.   

Abstract

Histone-modifying enzymes play a pivotal role in gene expression and repression. In human, DOT1L (Dot1-like) is the only known histone H3 lysine 79 methyltransferase. hDOT1L is associated with transcriptional activation, but the general mechanism connecting hDOT1L to active transcription remains largely unknown. Here, we report that hDOT1L interacts with the phosphorylated C-terminal domain of actively transcribing RNA polymerase II (RNAPII) through a region conserved uniquely in multicellular DOT1 proteins. Genome-wide profiling analyses indicate that the occupancy of hDOT1L largely overlaps with that of RNAPII at actively transcribed genes, especially surrounding transcriptional start sites, in embryonic carcinoma NCCIT cells. We also find that C-terminal domain binding or H3K79 methylations by hDOT1L is important for the expression of target genes such as NANOG and OCT4 and a marker for pluripotency in NCCIT cells. Our results indicate that a functional interaction between hDOT1L and RNAPII targets hDOT1L and subsequent H3K79 methylations to actively transcribed genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012353      PMCID: PMC3501035          DOI: 10.1074/jbc.M112.384057

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS.

Authors:  Jung-Shin Lee; Abhijit Shukla; Jessica Schneider; Selene K Swanson; Michael P Washburn; Laurence Florens; Sukesh R Bhaumik; Ali Shilatifard
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

Review 2.  Histone ubiquitination: triggering gene activity.

Authors:  Vikki M Weake; Jerry L Workman
Journal:  Mol Cell       Date:  2008-03-28       Impact factor: 17.970

3.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

4.  Histone H2B ubiquitylation controls processive methylation but not monomethylation by Dot1 and Set1.

Authors:  Mona D Shahbazian; Kangling Zhang; Michael Grunstein
Journal:  Mol Cell       Date:  2005-07-22       Impact factor: 17.970

5.  Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain.

Authors:  Qin Feng; Hengbin Wang; Huck Hui Ng; Hediye Erdjument-Bromage; Paul Tempst; Kevin Struhl; Yi Zhang
Journal:  Curr Biol       Date:  2002-06-25       Impact factor: 10.834

6.  Lysine-79 of histone H3 is hypomethylated at silenced loci in yeast and mammalian cells: a potential mechanism for position-effect variegation.

Authors:  Huck Hui Ng; David N Ciccone; Katrina B Morshead; Marjorie A Oettinger; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

7.  Structure and regulation of the mDot1 gene, a mouse histone H3 methyltransferase.

Authors:  Wenzheng Zhang; Yoshihide Hayashizaki; Bruce C Kone
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

8.  Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast.

Authors:  Zu-Wen Sun; C David Allis
Journal:  Nature       Date:  2002-06-23       Impact factor: 49.962

9.  Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase.

Authors:  Nicolas Lacoste; Rhea T Utley; Joanna M Hunter; Guy G Poirier; Jacques Côte
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

10.  Evolutionary conservation levels of subunits of histone-modifying protein complexes in fungi.

Authors:  Hiromi Nishida
Journal:  Comp Funct Genomics       Date:  2009-05-18
View more
  36 in total

Review 1.  The upstreams and downstreams of H3K79 methylation by DOT1L.

Authors:  Hanneke Vlaming; Fred van Leeuwen
Journal:  Chromosoma       Date:  2016-01-04       Impact factor: 4.316

Review 2.  Targeting epigenetic mechanisms for chronic visceral pain: A valid approach for the development of novel therapeutics.

Authors:  Tijs Louwies; Casey O Ligon; Anthony C Johnson; Beverley Greenwood-Van Meerveld
Journal:  Neurogastroenterol Motil       Date:  2018-11-04       Impact factor: 3.598

Review 3.  The emerging roles of DOT1L in leukemia and normal development.

Authors:  C M McLean; I D Karemaker; F van Leeuwen
Journal:  Leukemia       Date:  2014-05-23       Impact factor: 11.528

Review 4.  Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.

Authors:  David F Tough; Huw D Lewis; Inmaculada Rioja; Matthew J Lindon; Rab K Prinjha
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

Review 5.  Getting down to the core of histone modifications.

Authors:  Antonia P M Jack; Sandra B Hake
Journal:  Chromosoma       Date:  2014-05-02       Impact factor: 4.316

Review 6.  Histone Marks in the 'Driver's Seat': Functional Roles in Steering the Transcription Cycle.

Authors:  Leah A Gates; Charles E Foulds; Bert W O'Malley
Journal:  Trends Biochem Sci       Date:  2017-11-06       Impact factor: 13.807

7.  Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.

Authors:  Aravinda Kuntimaddi; Nicholas J Achille; Jeremy Thorpe; Alyson A Lokken; Ritambhara Singh; Charles S Hemenway; Mazhar Adli; Nancy J Zeleznik-Le; John H Bushweller
Journal:  Cell Rep       Date:  2015-04-23       Impact factor: 9.423

8.  Structural Basis of Dot1L Stimulation by Histone H2B Lysine 120 Ubiquitination.

Authors:  Marco Igor Valencia-Sánchez; Pablo De Ioannes; Miao Wang; Nikita Vasilyev; Ruoyu Chen; Evgeny Nudler; Jean-Paul Armache; Karim-Jean Armache
Journal:  Mol Cell       Date:  2019-04-10       Impact factor: 17.970

9.  Chromatin Architecture of the Pitx2 Locus Requires CTCF- and Pitx2-Dependent Asymmetry that Mirrors Embryonic Gut Laterality.

Authors:  Ian C Welsh; Hojoong Kwak; Frances L Chen; Melissa Werner; Lindsay S Shopland; Charles G Danko; John T Lis; Min Zhang; James F Martin; Natasza A Kurpios
Journal:  Cell Rep       Date:  2015-09-24       Impact factor: 9.423

10.  The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target.

Authors:  Matthew Wong; Patsie Polly; Tao Liu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.